Product Information
Tafolecimab (IBI-306), an IgG2 monoclonal antibody, targets PCSK-9 to lower LDL-C by preserving LDL receptors.
Chemical properties
Technical inquiry about: TM-T76974 Tafolecimab
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.